Elvitegravir

規格

697761-98-1CAS番号

691-248-4EC番号

6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acidIUPAC名

C23H23ClFNO5化学式

447.9 g/mol分子量

Elvitegravir; 697761-98-1; GS-9137; JTK-303; Vitekta; GS 9137; JTK 303; elvitegravirum; JTK303; CHEBI:72289; GS9137; 4GDQ854U53; 6-(3-chloro-2-fluorobenzyl)-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; DTXSID101021650; VITEKTA COMPONENT ELVITEGRAVIR; STRIBILD COMPONENT ELVITEGRAVIR; 3-Quinolinecarboxylic acid, 6-((3-chloro-2-fluorophenyl)methyl)-1,4-dihydro-1-((1S)-1-(hydroxymethyl)-2-methylpropyl)-7-methoxy-4-oxo-; 6-(3-Chloro-2-fluorobenzyl)-1-((2S)-1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; RefChem:58903; J05AX11; DTXCID101506658; 691-248-4; Elvitegravir (GS-9137); UNII-4GDQ854U53; (S)-6-(3-chloro-2-fluorobenzyl)-1-(1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; EVG; MFCD11846134; 6-(3-Chloro-2-fluorobenzyl)-1-[1(S)-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; CHEMBL204656; 6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid; Elvitegravir (GS-9137, JTK-303); C23H23CLFNO5; 6-(3-chloro-2-fluorobenzyl)-1-[(1S)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 6-[(3-chloro-2-fluoro-phenyl)methyl]-1-[(1S)-1-(hydroxymethyl)-2-methyl-propyl]-7-methoxy-4-oxo-quinoline-3-carboxylic acid; Elvitegravir [USAN]; Elvitegravir [USAN:INN]; Elvitegravir (JTK-303); 6-(3-CHLORO-2-FLUOROBENZYL)-1-((1S)-1-(HYDROXYMETHYL)-2-METHYLPROPYL)-7-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID; ELV; Vitekta (TN); Elvitegravir (Standard); ELVITEGRAVIR [MI]; Elvitegravir (JAN/USAN); ELVITEGRAVIR [INN]; ELVITEGRAVIR [JAN]; ELVITEGRAVIR [VANDF]; ELVITEGRAVIR [MART.]; MLS006011136; ELVITEGRAVIR [WHO-DD]; SCHEMBL726252; orb1224206; SCHEMBL29623981; GTPL11574; JUZYLCPPVHEVSV-LJQANCHMSA-N; ELVITEGRAVIR [ORANGE BOOK]; GLXC-05860; EX-A1542; BDBM50183273; EBC-11372; HY-14740R; MSK159130; s2001; Elvitegravir; GS9137; JTK 303; AKOS025396642; CCG-269208; compound 2 [PMID: 18281931]; CS-0439; DB09101; NCGC00346565-01; NCGC00346565-04; NCGC00346565-05; NCGC00346565-08; 6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; AC-29947; AS-16986; HY-14740; SMR004702914; E4785; NS00040665; SW219721-1; D06677; AB01274749-01; AB01274749_02; EN300-19771136; F547237; Q2740966; BRD-K54472332-001-01-8; BRD-K54472332-001-03-4; 3-Quinolinecarboxylic acid, 6-[(3-chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1S)-1-isopropyl-2-hydroxyethyl]-7-methoxy-4-oxo-; 6-(3-chloro-2-fluorobenzyl)-1-[(S)-1-hydroxymethyl-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; Elvitegravir Micronized別名